May 22, 2020
Date: Aug 10, 2023
FDA has a new Commissioner, industry is debating if the 25-year-old dietary supplement laws should be updated, and consumer class action lawsuits continually filed. What does the future hold for the regulation of probiotics (and prebiotics and postbiotics) in foods, dietary supplements and cosmetics? Anticipating legal roadblocks is key to success for brands that are considering launching a new product or have a product already on the market. Ivan Wasserman will provide the latest information and answer your questions.
Ivan Wasserman, managing partner, Amin Talati Wasserman LLP
Ivan Wasserman is the Managing Partner of leading regulatory and intellectual property law firm Amin Talati Wasserman LLP. Noted for expertise in foods, dietary supplements and cosmetics, Ivan and his team represent clients before the FDA, the FTC, State Attorneys General, and in class action litigation. Ivan also serves as counsel to the International Probiotics Association, is a frequent speaker and author on regulatory issues, and has been included in Best Lawyers in America from 2007 to 2020.
You May Also Like
The rise of ashwagandha: A case study in a growing and evolving category – articleNov 28, 2023
Ashwagandha: Roots for wellness, leaves for soil – articleNov 28, 2023
Creatine, whey protein, beta-alanine among picks in NFL-style draft at SupplySide WestDec 01, 2023
Unleash the power of ‘combos’ supplements to meet consumer demand – infographicNov 22, 2023